Search results for "Heart Failure"
Diagnose, address cognitive impairment in heart failure patients, society says
A new scientific statement from the Heart Failure Society of America advises clinicians to be alert to clues such as difficulty with money or running out of medicine, among other recommendations.
https://immattersacp.org/weekly/archives/2024/03/19/4.htm
19 Mar 2024
Treat COPD symptoms, solve problems
Effectively managing chronic obstructive pulmonary disease means staying up to date on medications, devices, and delivery techniques.
https://immattersacp.org/archives/2024/04/treat-copd-symptoms-solve-problems.htm
1 Apr 2024
Adherence to sleep apnea treatment reduces health care use, costs in heart failure
Positive airway pressure-adherent patients with heart failure with preserved ejection fraction and obstructive sleep apnea had fewer health care visits, including ED and hospital visits, than nonadherent patients, according to a new industry-funded study.
https://immattersacp.org/weekly/archives/2023/07/18/2.htm
18 Jul 2023
Digoxin still used, but toxicity not appreciated
Add digoxin toxicity to your checklist of diagnostic suspicions, and consider standing orders to check serum levels in certain populations.
https://immattersacp.org/archives/2024/04/digoxin-still-used-but-toxicity-not-appreciated.htm
1 Apr 2024
Frailer heart failure patients less likely to receive guideline-recommended therapy
A prospective analysis of patients with heart failure and reduced ejection fraction in Japan found that the proportion receiving angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists decreased as physical frailty increased.
https://immattersacp.org/weekly/archives/2023/06/20/4.htm
20 Jun 2023
Salt tablets no salve for hyponatremia
At Kidney Week in fall 2023, an endocrinologist covered the latest in outpatient diagnosis and treatment of syndrome of inappropriate antidiuresis (SIAD).
https://immattersacp.org/archives/2024/02/salt-tablets-no-salve-for-hyponatremia.htm
1 Feb 2024
Quadruple therapy for heart failure cost-effective compared to previous standard of care
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
https://immattersacp.org/weekly/archives/2023/06/13/1.htm
13 Jun 2023
ED, outpatient visits for worsening heart failure on the rise since 2010
A cohort study that analyzed encounters in one health system for worsening heart failure found that ED and observation stays and outpatient visits account for approximately half of the visits, with hospitalizations comprising the other half.
https://immattersacp.org/weekly/archives/2022/07/05/5.htm
5 Jul 2022
First medication for severe frostbite approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/04/first-medication-for-severe-frostbite-approved.htm
1 Apr 2024
Meta-analysis compares mortality benefits of heart failure treatment combinations
Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021